Table 2 Patients characteristics detected drug-resistant bacteria and choice of antibiotics
No. | Pneumonia Panel | Culture test | Gram Stain | Geckler | Septic shock | Antibiotics used before the test | Choice of antibiotics | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Resistance gene | Detected pathogens | c/mL | Detected pathogens | GNC | GPC | GNR | GPR | Fungus | ||||||
1 | Staphylococcus aureus | >107 | Staphylococcus aureus | 1+ | - | 2+ | - | - | - | 5 | - | MEPM | No change (MEPM) | |
Pseudomonas aeruginosa | 104 | |||||||||||||
Streptococcus agalactiae | 106 | |||||||||||||
2 | Escherichia coli | >107 | Klebsiella pneumoniae | 3+ | - | 4+ | 4+ | 4+ | 4+ | 4 | + | ー | Escalation (LZD) | |
Klebsiella pneumoniae group | >107 | α-Streptococcus sp | 2+ | |||||||||||
mecA/C and MREJ | Staphylococcus aureus | >107 | Candida sp | 3+ | ||||||||||
Streptococcus agalactiae | >107 | |||||||||||||
Streptococcus pneumoniae | >107 | |||||||||||||
3 | Pseudomonas aeruginosa | >107 | Pseudomonas aeruginosa | 1+ | - | 4+ | 1+ | 1+ | - | 5 | + | ABPC/SBT | Escalation (TAZ/PIPC) | |
4 | Pseudomonas aeruginosa | >107 | Pseudomonas aeruginosa | 1+ | - | 1+ | 2+ | - | - | 5 | - | CMZ | No change (CMZ) | |
mecA/C and MREJ | Staphylococcus aureus | 105 | ||||||||||||
5 | CTX-M | Escherichia coli | 104 | Escherichia coli(ESBL) | 1+ | - | 4+ | 1+ | - | - | 5 | - | CEZ | Protocol (ABPC/SBT) |
Streptococcus pneumoniae | 106 | Streptococcus pneumoniae | 2+ | |||||||||||
6 | mecA/C and MREJ | Staphylococcus aureus | 106 | Staphylococcus aureus(MRSA) | 1+ | - | 1+ | 1+ | - | 3+ | 4 | + | ー | Protocol (ABPC/SBT) |
Enterobacter cloacae complex | 105 | Candida sp | 1+ | |||||||||||
7 | Pseudomonas aeruginosa | 104 | Pseudomonas aeruginosa | 1+ | - | 1+ | - | - | 1+ | - | - | MEPM | No change (MEPM) | |
α-Streptococcus sp | 1+ | |||||||||||||
Candida sp | 1+ | |||||||||||||
8 | Klebsiella pneumoniae group | >107 | Klebsiella pneumoniae | 2+ | - | 2+ | 2+ | 1+ | - | 3 | - | ー | Escalation (VCM+CFPM) | |
Pseudomonas aeruginosa | 105 | Candida sp | 1+ | |||||||||||
mecA/C and MREJ | Staphylococcus aureus | >107 | Staphylococcus aureus | 2+ | ||||||||||
9 | Moraxella catarralis | 104 | Corynebacterium sp | 2+ | - | 1+ | 2+ | 2+ | 1+ | 3 | - | ー | Escalation (LZD) | |
mecA/C and MREJ | Staphylococcus aureus | 104 | Candida sp | 1+ | ||||||||||
10 | Staphylococcus aureus | 104 | Staphylococcus aureus | 2+ | 1+ | 4+ | 1+ | 1+ | - | 3 | + | ー | Protocol (ABPC/SBT) | |
CTX-M | Escherichia coli | 104 | α-Streptococcus sp | 3+ | ||||||||||
11 | CTX-M | Acinetobacter calcoaceticusbaumannii complex | 106 | Citrobacter sp | 3+ | - | 2+ | 4+ | 4+ | - | 3 | - | ABPC/SBT | Escalation (MEPM) |
Corynebacterium sp | 3+ | |||||||||||||
12 | mecA/C and MREJ | Staphylococcus aureus | >107 | Staphylococcus aureus(MRSA) | 3+ | - | 3+ | - | 3+ | - | 3 | - | ー | Escalation (LZD) |
Human Metapneumovirus | α-Streptococcus sp | 3+ | ||||||||||||